A practical microwave method for the synthesis of fluoromethy 4-methylbenzenesulfonate in tert-amyl alcohol by Brocklesby, K.L. et al.
Tetrahedron Letters 59 (2018) 1635–1637Contents lists available at ScienceDirect
Tetrahedron Letters
journal homepage: www.elsevier .com/locate / tet le tA practical microwave method for the synthesis of fluoromethy
4-methylbenzenesulfonate in tert-amyl alcoholhttps://doi.org/10.1016/j.tetlet.2018.03.039
0040-4039/ 2018 The Authors. Published by Elsevier Ltd.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
⇑ Corresponding author.
E-mail address: graham.smith@icr.ac.uk (G. Smith).Kayleigh L. Brocklesby a,b, Jennifer S. Waby c, Christopher Cawthorne d, Graham Smith b,⇑
aHull-York Medical School, University of York, Heslington, York YO10 5DD, UK
bDivision of Radiotherapy and Imaging, Institute of Cancer Research, London SW7 3RP, UK
c Faculty of Life Sciences, Richmond Building Room H15, University of Bradford, Bradford, West Yorkshire BD7 1DP, UK
d PET Research Centre, University of Hull, Cottingham Road, Hull HU6 7RX, UK
a r t i c l e i n f o a b s t r a c tArticle history:
Received 14 January 2018
Revised 12 March 2018
Accepted 15 March 2018
Available online 16 March 2018
Keywords:
PET
Fluorination
Microwave
Fluoromethyl tosylate
Tert-amyl alcoholFluorine substitution is an established tool in medicinal chemistry to favourably alter the molecular prop-
erties of a lead compound of interest. However, gaps still exist in the library of synthetic methods for
accessing certain fluorine-substituted motifs. One such area is the fluoromethyl group, particularly when
required in a fluoroalkylating capacity. The cold fluorination of methylene ditosylate is under evaluated
in the literature, often proceeding with low yields or harsh conditions. This report describes a novel
microwave method for the rapid nucleophilic fluorination of methylene ditosylate using inexpensive
reagents in good isolated yield (65%).
 2018 The Authors. Published by Elsevier Ltd. This is an openaccess article under the CCBY license (http://
creativecommons.org/licenses/by/4.0/).Introduction
The use of fluorine in medicinal chemistry and agrochemicals
has grown rapidly in recent years, culminating in approximately
one third of the top selling drugs in the world containing at least
one fluorine atom.1 This design trend is a result of the unique prop-
erties of fluorine such as high electronegativity, high carbon–fluo-
rine bond strength and small steric size, which enable fluorine to
impart substantial changes in molecular properties such as
lipophilicity/bioavailability and metabolic stability at minimal
steric cost.2,3 A further avenue of interest for fluorine is nuclear
medicine, specifically Positron Emission Tomography (PET), where
incorporation of cyclotron-produced fluorine-18 into radiophar-
maceuticals is of widespread interest.4 For PET applications the
stable isotope analogue is also required to enable accurate confir-
mation of product identity by radio-chromatographic methods.
Fluoromethylation is an underexplored strategy in both medic-
inal chemistry and nuclear medicine, partly as a result of the com-
plex synthetic methodology required to access the necessary
structures. The alkylating fragment [18F]fluoromethyl 4-methyl-
benzenesulfonate (‘‘[18F]fluoromethyl tosylate”) is well-estab-
lished in radiochemistry for the automated, GMP-compatibleradiosynthesis of [18F]fluoromethyl choline.5,6 Consequently, it
would be advantageous to access both the radiochemistry precur-
sor and the stable isotope standard via the same fluoromethylation
pathway to minimise synthetic effort. Fluoromethyl bromide and
fluoromethyl iodide have been used in this capacity but are either
a volatile greenhouse gas (FCH2Br) or are not commercially avail-
able and are troublesome to synthesise (FCH2I). Fluoromethyl tosy-
late is not volatile but current methods to access this reagent are
typically low-yielding or use expensive reagents such as phase-
transfer agents (Kryptofix K222 or 18-crown-6).7,8 Herein, we report
a method for rapid access to stable isotope fluoromethyl tosylate
from inexpensive reagents to complement radiochemical methods
to access [18F]fluoromethyl tosylate.
A survey of the literature was carried out to identify conditions
for the conversion of methylene distosyate 1 to fluoromethyl tosy-
late 2, with minimal formation of the by-product tosyl fluoride 3
(Scheme 1). Our efforts to replicate previously reported conditions
and also independently identify suitable reaction parameters are
summarised in Table 1. When the fluorination was attempted in
the presence of acetonitrile and using caesium fluoride (Entry 2)
this reaction gave an inadequate 5% conversion. Conversion to
the by-product p-tosyl fluoride 3 was identified by 1H NMR (see
ESI for the 1H NMR spectrum of 3). The use of microwave heating
to effect fluoride displacement of a sulfonate by Qu and co-workers
provided a rationale for our investigation in this area.9 Previous
reports have described radiolabelling via the nucleophilic
Scheme 1. Fluorination of methylene ditosylate.
Table 1
Preliminary evaluation of reaction conditions for the synthesis of fluoromethyl tosyate 2a.
Entry Solvent MF/catalyst (eq.) Temp (C) Time (h) Conversion (%)b Refs.
1 2 3
1c MeCN TBAF 110 0.5 100 – – This work
2c MeCN CsF 110 0.5 95 5 – This work
3 MeCN KF/K222 (1.4) 110 1 85 15 – 8
4 DMF CsF 120 24 75 5 20 This work
5 DMSO CsF 120 24 100 – – This work
6c THF TBAF 110 0.5 100 – – 9
7d t-Amyl alcohol CsF 80 6 – 100 – 10
8d t-BuOH CsF 80 6 57 43 – 10
a Unless otherwise stated, all reactions were carried out using 0.06 mmol of 1, 0.12 mmol of CsF, in 1 mL of the specified solvent.
b Conversion determined by 1H NMR.
c Microwave irradiation.
d 3 Equivalents of CsF were used.
Table 2
Microwave synthesis of 2a.
Entry Temp. (C) Time (min) Conversion(%)b
1 2 3
1 80 30 – 95 5
2 80 15 45 55 –
3 90 15 – 95 5
a Reactions conducted in 1 mL of t-amyl alcohol, using 0.06 mmol of 1 and 0.3 of
CsF (n = 3).
b conversion determined by 1H NMR.
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Application of these conditions to a bulk scale with greatly
increased stoichiometry of the fluoride source compared to the
radiolabelling reaction (Entries 4 and 5) and more polar aprotic sol-
vents yielded a 20% conversion to tosyl fluoride 3 again, with an
inadequate conversion to 2. A potential alternative strategy for flu-
oride displacement of an alkyl sulfonate leaving group is the use of
a tertiary alcohol solvent.10,11 Gratifyingly, application of the reac-
tion conditions reported by Kim and co-workers (Entry 7) yielded a
100% conversion to the fluoromethyl tosylate 2. It is thought that
the partial positive charge of the polar protic solvent aids the fluo-
ride ion by increasing its nucleophilicity through weakening of the
ionic cesium-fluorine bond and enhancing the leaving group ability
of the tosylate group through hydrogen bonding.11
Upon identifying conditions suitable for the synthesis of fluo-
romethyl tosylate, attempted optimisation of the reaction as a pre-Fig. 1. Equivalent dependant conversion to 2 over time. N = 3. Reported as average
with the error bars indicating standard deviation. ^No standard deviation observed
for these bars.requisite for larger-scale synthesis was investigated. Therefore, the
effect of temperature, reaction time and excess of cesium fluoride
on the conversion of 1 to fluoromethyl tosylate 2 or tosyl fluoride 3
was studied. Fig. 1 clearly demonstrates the use of one equivalent
of caesium fluoride is less than satisfactory, never achieving above
a 16% conversion. Although two equivalents of caesium fluoride isTable 3
Scale up conditionsa (A t-amyl alcohol was removed under reduced pressure then
extracted with the stated solvent. B poured onto water then extracted with the stated
solvent. C solvent added to the microwave vial then sonicated to break up the
reaction mixture then filtered and washed with the solvent. The filtrate was
concentrated under reduced pressure. D t-amyl alcohol removed under reduced
pressure and the solid was triturated with the stated solvent and the filtrate
concentrated under reduced pressure).
Entry Work up Solvent Yield 2b (%) Yield 3c (%)
1 A EtOAc 37 5
2 B Et2O 36 5
3 C EtOAc 38 5
4 C Et2O 88 2
5 C CH2Cl2 40 5
6 D EtOAc 60 5
7 D CH2Cl2 42 5
8d D Et2O 65 3
a Reactions conducted using 0.28 mmol of 1 and 1.4 mmol of CsF in 5 mL of t-
amyl alcohol.
b Isolated yield.
c Determined by 1H NMR.
d Reaction conducted with 1.4 mmol of 1, and 7 mmol of CsF in 5 mL of t-amyl
alcohol.
K.L. Brocklesby et al. / Tetrahedron Letters 59 (2018) 1635–1637 1637sufficient to achieve an average of 87% conversion after 6 h, with
no traceable starting material 1, five equivalents achieves full
conversion after one hour (see ESI, Table S1 for the full table).
Conditions were further optimised by studying the effect of tem-
perature and reaction duration (Table 2).
Probing this nucleophilic fluorination on a larger scale afforded
unexpected problems, notably a low isolated yield of 37%. Table 3
summarises different work-up conditions that were attempted in
order to improve the isolated yield. As highlighted by Entry 8,
the optimal work-up conditions were removal of the residual
t-amyl alcohol followed by trituration of the resultant solid with
diethyl ether and concentration of the filtrate to furnish
fluoromethyl tosylate in 65% isolated yield.
In summary we have reported conditions for the synthesis of
fluoromethyl tosylate on a bulk scale that are superior to those pre-
viously reported. Reaction times of 15 min were achieved in the
microwave using tert-amyl alcohol, obtaining a best isolated yield
of 65%. These results will facilitate further adoption of this impor-
tant functionality in medicinal chemistry and nuclear medicine.
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